http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102198129-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
| filingDate | 2011-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102198129-B |
| titleOfInvention | Oral tablet containing candesartan Cilexetil and hydrochlorothiazide |
| abstract | The invention discloses a kind of oral tablet containing candesartan Cilexetil and hydrochlorothiazide, by hydrochlorothiazide, particle diameter Dn (V, 0.9) be the candesartan Cilexetil of 20 μm-100 μm and pharmaceutic adjuvant composition, wherein said pharmaceutic adjuvant comprises stabilizing agent and other adjuvants as one or more in filler, binding agent, disintegrating agent.Candesartan Cilexetil hydrochlorothiazide tablet provided by the invention is unilateral attractive in appearance, and steady quality, bioavailability is high.The present invention also provides the preparation method of this oral tablet described, and technique is simple, and cost is lower, is more suitable for commercially producing. |
| priorityDate | 2011-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 68.